Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer-Reference-Cited by-同舟云学术

Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer

Published:2016-09-15 Issue:45 Volume:7 Page:73618-73637
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Guerrab Abderrahim El¹²,Bamdad Mahchid²³,Kwiatkowski Fabrice¹,Bignon Yves-Jean¹²,Penault-Llorca Frédérique¹²,Aubel Corinne¹²

Affiliation:

1. Centre Jean Perrin - ERTICa-EA4677, BP392, 63011 Clermont-Ferrand Cedex, France

2. Clermont Université - Université d'Auvergne - ERTICa-EA4677, Faculté de Médecine, BP38, 63001 Clermont-Ferrand Cedex, France

3. Clermont Université - Université d'Auvergne - ERTICa-EA4677, Institut Universitaire de Technologie, Département Génie Biologique, Ensemble Universitaire des Cézeaux, BP86, 63172 Aubière Cedex, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico analysis of secondary metabolites from Abrus precatorius L. leaves as a novel approach to breast cancer treatment;Journal of Pharmacy & Pharmacognosy Research;2025-01-01

2. The molecular basis of the anticancer effect of statins;Scientific Reports;2024-08-31

3. An Investigation into the In Vitro Targeted Killing of CD44-Expressing Triple-Negative Breast Cancer Cells Using Recombinant Photoimmunotherapeutics Compared to Auristatin-F-Based Antibody-Drug Conjugates;Molecular Pharmaceutics;2024-07-24

4. Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach;Pharmaceutics;2024-07-11

5. Caspase-9 suppresses metastatic behavior of MDA-MB-231 cells in an adaptive organoid model;Scientific Reports;2024-07-02